Background:
Prognostic factors of breast cancer have been used for the prediction of clinical outcome or selection of patients for complementary treatment. Some of the imaging features of breast cancer, e.g. magnetic resonance imaging (MRI), are associated with these prognostic factors.
Purpose:
To evaluate the relationship between dynamic enhanced MR features and prognostic factors of clinical outcome of breast cancer.
Material And Methods:
A total of 136 patients with 151 breast cancers underwent 1.5T dynamic MR imaging with the use of a dynamic T1-weighted three-dimensional fast low-angle shot (FLASH) subtraction imaging technique. Morphological and kinetic analyses of MR features were evaluated using the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) MRI lexicon. Pathological prognostic factors were correlated with MR imaging characteristics, including tumor size, histological grade, lymph node status, expression of estrogen receptor (ER), expression of progesterone receptor (PR), expression of c-erbB2, determination of Ki-67 index, and microvascular density (MVD), using univariate and multivariate statistical analyses.
Results:
Based on univariate and multivariate analyses, spiculated tumor margins correlated significantly with lower histological grade (I-II) and positive PR expression. Rim enhancement was significantly correlated with high histological grade, presence of axillary lymph node metastasis, large tumor size, increased Ki-67 index, and increased MVD. Early peak enhancement, as seen on the first scan after contrast medium injection, was correlated with negative ER expression.
Conclusion:
The presence of a lesion with a spiculated margin may predict a relatively good prognosis, and the presence of a lesion with rim enhancement may predict a relatively poor prognosis.
Citing Articles
High-risk breast lesions: a combined intratumoral and peritumoral radiomics nomogram model to predict pathologic upgrade and reduce unnecessary surgical excision.
Liao T, Yang Y, Lin X, Ouyang R, Deng Y, Ma J
Front Oncol. 2025; 14:1479565.
PMID: 39744004
PMC: 11688276.
DOI: 10.3389/fonc.2024.1479565.
Ki-67 With MRI in Predicting the Complete Pathological Response Post-neoadjuvant Chemotherapy.
Kolli M, George A, Aoutla S, Chandrasekar S, Girivasan S, Kolli R
Cureus. 2024; 16(11):e73469.
PMID: 39534551
PMC: 11555758.
DOI: 10.7759/cureus.73469.
Magnetic resonance imaging features of invasive breast cancer association with the tumour stromal ratio.
Ab Mumin N, Ramli Hamid M, Hamid S, Chiew S, Ahmad Saman M, Rahmat K
PLoS One. 2023; 18(8):e0290772.
PMID: 37624821
PMC: 10456176.
DOI: 10.1371/journal.pone.0290772.
Diagnostic accuracy of contrast-enhanced ultrasound synchronized with shear wave elastography in the differential diagnosis of benign and malignant breast lesions: a diagnostic test.
He H, Wu X, Jiang M, Xu Z, Zhang X, Pan J
Gland Surg. 2023; 12(1):54-66.
PMID: 36761482
PMC: 9906099.
DOI: 10.21037/gs-22-684.
Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
Liu Y, Li X, Zhu L, Zhao Z, Wang T, Zhang X
Contrast Media Mol Imaging. 2022; 2022:6729473.
PMID: 36051932
PMC: 9410821.
DOI: 10.1155/2022/6729473.
Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.
Kazama T, Takahara T, Hashimoto J
Life (Basel). 2022; 12(4).
PMID: 35454981
PMC: 9028183.
DOI: 10.3390/life12040490.
Development and Internal Validation of a Preoperative Prediction Model for Sentinel Lymph Node Status in Breast Cancer: Combining Radiomics Signature and Clinical Factors.
Wang C, Chen X, Luo H, Liu Y, Meng R, Wang M
Front Oncol. 2021; 11:754843.
PMID: 34820327
PMC: 8606782.
DOI: 10.3389/fonc.2021.754843.
Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
Peng J, Pu H, Jia Y, Chen C, Ke X, Zhou Q
Medicine (Baltimore). 2021; 100(19):e25908.
PMID: 34106653
PMC: 8133101.
DOI: 10.1097/MD.0000000000025908.
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?.
Moffa G, Galati F, Collalunga E, Rizzo V, Kripa E, dAmati G
Diagnostics (Basel). 2020; 10(12).
PMID: 33333733
PMC: 7765199.
DOI: 10.3390/diagnostics10121090.
Correlation between apparent diffusion coefficient values in breast magnetic resonance imaging and prognostic factors of breast invasive ductal carcinoma.
Moutinho-Guilherme R, Oyola J, Sanz-Rosa D, Vassallo I, Garcia R, Pisco J
Porto Biomed J. 2019; 4(1):e27.
PMID: 31595254
PMC: 6750250.
DOI: 10.1016/j.pbj.0000000000000027.
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores.
Wan T, Bloch B, Plecha D, Thompson C, Gilmore H, Jaffe C
Sci Rep. 2016; 6:21394.
PMID: 26887643
PMC: 4757835.
DOI: 10.1038/srep21394.
Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Chen J, Yu H, Hsu C, Mehta R, Carpenter P, Su M
Transl Oncol. 2015; 8(3):204-9.
PMID: 26055178
PMC: 4487259.
DOI: 10.1016/j.tranon.2015.04.001.
Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.
Szabo B, Saracco A, Tanczos E, Aspelin P, Leifland K, Wilczek B
Eur Radiol. 2013; 23(12):3228-36.
PMID: 23821023
DOI: 10.1007/s00330-013-2960-5.
Correlations between diffusion-weighted imaging and breast cancer biomarkers.
Martincich L, Deantoni V, Bertotto I, Redana S, Kubatzki F, Sarotto I
Eur Radiol. 2012; 22(7):1519-28.
PMID: 22411304
DOI: 10.1007/s00330-012-2403-8.